Form 13-F position report

CRESCENT BIOPHARMA INC.

Reported by Vestal Point Capital LP

CBIO CUSIP G2545C104 Manager CIK 0001974915

Reported 3,000,000 shares, up 1,370,000 (84.0%) from the prior quarter.

Reported value 49.2%; share count 84.0% vs. the prior quarter.

Added
% of reported 13F value 1.13% This manager · Q3 2026
Shares 3,000,000 Quarter-end amount reported
Reported value $43,770,000 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-12-31 17790000
2026-03-31 27555000
2026-06-30 29340000
2026-09-30 43770000

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for CRESCENT BIOPHARMA INC. held by Vestal Point Capital LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 3,000,000 +1,370,000 (84.0%) 1.13% $43,770,000 2026-11-16
Q2 2026 Added 1,630,000 +130,000 (8.7%) 0.69% $29,340,000 2026-08-14
Q1 2026 Unchanged 1,500,000 0 (0.0%) 0.77% $27,555,000 2026-05-15
Q4 2025 New 1,500,000 +1,500,000 (0.0%) 0.6% $17,790,000 2026-02-17

Who else reported the position

118 managers reported CRESCENT BIOPHARMA INC. for Q3 2026.

Managers reporting CRESCENT BIOPHARMA INC. in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 5,904,998 +1,771,484 < 0.01% $86,153,921 6 qtrs
Fairmount Funds Management LLC Added 3,601,316 +853,450 3.3% $52,543,200 6 qtrs
BVF INC IL Added 3,093,590 +344,827 1.48% $45,135,478 6 qtrs
Vestal Point Capital LP This report Added 3,000,000 +1,370,000 1.13% $43,770,000 4 qtrs
BlackRock Inc Added 2,138,232 +866,470 < 0.01% $31,196,805 6 qtrs
VR Adviser LLC Added 2,133,734 +158 1.51% $31,131,179 6 qtrs
FCPM III SERVICES B V Added 2,022,679 +344,827 2.78% $29,510,887 4 qtrs
Opaleye Management Inc Added 1,645,984 +326,633 2.71% $24,014,907 4 qtrs
Balyasny Asset Management LLC Reduced 1,611,958 -50,959 0.03% $23,518,467 4 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 1,268,637 +500,882 < 0.01% $18,509,414 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
3,000,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.